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Tubal ectopic pregnancy (EP) is the most common
cause of maternal mortality in the first trimester of
pregnancy; however, its etiology is uncertain. In EP,
embryo retention within the Fallopian tube (FT) is
thought to be due to impaired smooth muscle con-
tractility (SMC) and alterations in the tubal microen-
vironment. Smoking is a major risk factor for EP. FTs
from women with EP exhibit altered prokineticin re-
ceptor-1 (PROKR1) expression, the receptor for pro-
kineticins (PROK). PROK1 is angiogenic, regulates
SMC, and is involved in intrauterine implantation. We
hypothesized that smoking predisposes women to EP
by altering tubal PROKR1 expression. Sera/FT were
collected at hysterectomy (n  21). Serum levels of the
smoking metabolite, cotinine, were measured by en-
zyme-linked immunosorbent assay. FTs were analyzed
by q-RT-PCR, immunohistochemistry , and Western
blotting for expression of PROKR1 and the pre-
dicted cotinine receptor, nicotinic acetylcholine re-
ceptor -7 (AChR7). FT explants (n  4) and ovi-
ductal epithelial cells (cell line OE-E6/E7) were treated
with cotinine and an nAChR7 antagonist. PROKR1
transcription was higher in FTs from smokers (P <
0.01). nAChR7 expression was demonstrated in
FT epithelium. Cotinine treatment of FT explants
and OE-E6/E7 cells increased PROKR1 expression
(P < 0.05) , which was negated by cotreatment with
nAChR7 antagonist. Smoking targets human FTs
via nAChR7 to increase tubal PROKR1, leading to
alterations in the tubal microenvironment that could
predispose to EP. (Am J Pathol 2010, 177:2509–2515; DOI:
10.2353/ajpath.2010.100243)
Tubal ectopic pregnancy occurs in 1 to 2% of all preg-
nancies in Europe and the United States.1 In the Western
world, it remains the most common cause of maternal
mortality in the first trimester of pregnancy.1,2
Our current understanding of the underlying causes of
tubal ectopic is based predominantly on descriptive ob-
servations rather than interventive experimentation.3 Nev-
ertheless, these observations support the hypothesis that
tubal implantation is likely caused by embryo retention
within the Fallopian tube due to impaired smooth muscle
contractility and alterations in the tubal environment al-
lowing implantation to occur. Transport of the embryo
through the Fallopian tube is controlled by a combination
of smooth muscle contractility and ciliary beating.4,5 The
factors that regulate and maintain the normal tubal ho-
meostatic environment are unknown.
Epidemiological studies have shown that cigarette
smoking is a risk factor for tubal ectopic pregnancy.1,2,6
Animal and human studies have demonstrated effects on
oviductal function resulting from smoke exposure. Inha-
lation of smoke has been reported to affect the electrical
activity of the rabbit oviduct,7 to reduce the ratio of cili-
ated to secretory epithelial cells in the hamster oviduct,8
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and to temporarily influence patency of human Fallopian
tube.9 Despite these findings, the exact mechanism by
which smoking leads to tubal ectopic pregnancy remains
unknown.
We recently reported down-regulated transcription of
two G-protein–coupled receptors, prokineticin receptor 1
(PROKR1) and PROKR2, in Fallopian tube from women
with tubal ectopic pregnancy, where implantation had
already occurred.10 Ligands for these receptors, the pro-
kineticins (PROK) 1 and PROK2, are proangiogenic. Pla-
cental PROK expression has been shown to be up-reg-
ulated in hypoxic conditions and, in the endometrium,
PROK1 is reported to increase the expression of proan-
giogenic cytokines.11,12 PROKs are also known for reg-
ulating genes that are important in implantation.13 PROK1
has been shown to induce expression of leukemia inhib-
itory factor (LIF) in the human endometrium, and LIF is
known to play a crucial role in successful intrauterine
implantation in mice.14,15 Furthermore, PROKs have been
shown to play a role in controlling smooth muscle con-
tractility in rodent gut, and are thought to similarly control
the tubal smooth muscle contractility which facilitates
embryo-tubal transport.10,16 We hypothesized that ciga-
rette smoking attenuates tubal PROKR expression result-
ing in changes in Fallopian tube function, providing a
possible explanation for the link between smoking and
tubal ectopic pregnancy.
Directly addressing this hypothesis in human subjects
is not straightforward, and interpretation of studies on the
physiological effects of smoke exposure can be difficult
due to technical constraints. Nicotine is the major con-
stituent of tobacco smoke but is difficult to measure or
study because of its very short half-life.17 Cotinine, the
most abundant metabolite of nicotine, has been identified
as a stable biomarker of smoke exposure and has been
used in cell culture to mimic the affects of smoke expo-
sure in vitro, reportedly signaling though the nicotinic
acetylcholine receptor -7 (nAChR7).17–19 Thus, to
objectively address our hypothesis, we compared serum
cotinine levels to PROKR expression in human Fallopian
tube. We also examined the effects of cotinine on tubal
PROKR expression in Fallopian tube in vitro and investi-
gated whether this was mediated via nAChR7.
Materials and Methods
Human Tissue Collection
Ethical approval for this study was obtained from the
Lothian Research Ethics Committee (04/S1103/20), and
informed consent was obtained from all of the women
participating in the study. Serum samples (10 ml) and
Fallopian tube biopsies (2–3 cm) from the ampullary re-
gion of the Fallopian tube were all collected from partic-
ipants at the time of hysterectomy (n  25). Women were
between 18 and 45 years of age. The clinical details for
each participant are listed in Table 1. A smoking his-
tory was obtained from all patients. None of the pa-
tients included in the study were known to have been
exposed to chlamydial infection. The biopsies were
divided into three portions and were either i) stored in
phosphate-buffered saline (PBS) before explant cul-
ture, ii) immersed in RNAlater (Ambion, Texas, USA) at
Table 1. Clinical Details for Patient Samples
Sample no.
Age
(years)
Serum estrogen
(pmol/L)
Serum progesterone
(nmol/L)
Reason for
surgery
Uterine
pathology
1 37 392.18 3.06 HMB No abnormality
2 41 1022.87 0.81 HMB Adenomyosis
3 37 940.44 3.82 HMB, PP Adenomyosis
4 44 829.42 4.19 HMB, PP Adeomyosis
5 36 770.63 5.16 HMB No abnormality
6 44 116.3 2.88 HMB, PP No abnormality
7 45 55.0 2.2 HMB, PP Adenomyosis
8 32 549.91 88 Dysmen No abnormality
9 40 242 53.1 HMB, dysmen No abnormality
10 43 201 24.55 HMB, PP Fibroid
11 43 399.8 80.45 HMB, dysmen Adenomyosis
12 40 1633.0 54.38 HMB, dysmen No abnormality
13 38 4.39 83 HMB, dysmen No abnormality
14 35 424 76.9 PP No abnormality
15 40 155.5 7.41 HMP, dysmen No abnormality
16 38 266 37.1 HMB No abnormality
17 43 242.9 38.1 HMB No abnormality
18 40 255 49.05 HMB No abnormality
19 35 73 2.67 HMB, dysmen Adenomyosis
20 37 392.18 3.06 Dysmen No abnormality
21 42 55 15.05 HMB No abnormality
Used in explant studies
22 38 38.2 7.09 HMB No abnormality
23 43 338.4 29.19 HMB Fibroid
24 46 282.2 22.29 HMB No abnormality
25 47 87.7 4.48 Dysmen No abnormality
HMB, heavy menstrual bleeding; PP, pelvic pain; dysmen, dysmenorrhoea.
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4°C overnight and then flash frozen at 80°C for RNA
extraction, or iii) fixed in 4% neutral-buffered formalin
overnight at 4°C followed by storage in 70% ethanol,
and subsequent embedding in paraffin wax for immu-
nohistochemical staining. Serum samples were stored
at 20°C until analysis.
ELISA for Serum Cotinine Levels
Serum cotinine levels were measured using the direct
cotinine ELISA kit (Immunalysis, Pomona, CA), according
to the manufacturer’s instructions. ELISA data were ana-
lyzed in conjunction with the smoking history provided by
the participants.
Quantitative RT-PCR for PROKR in Fallopian
Tube and the OE-E6/E7 Cell Line
RNA (200 ng) was reverse transcribed into cDNA in a
10-l reaction using random hexamers (Applied Bio-
systems, Foster City, CA). Taqman RT-PCR was used
to quantify PROK and PROKR mRNA transcript. Reac-
tions were performed using an ABI Prism 7900 (Ap-
plied Biosystems) using standard conditions. All prim-
ers and probes were previously validated,20 and the
sequences are listed in Table 2. All reactions were
performed in triplicate. Gene expression was normal-
ized to RNA loading using primers and VIC-labeled
probe (Applied Biosystems) for ribosomal 18S as an
internal standard and expressed as relative to a posi-
tive RNA standard (cDNA from a single mid-secretory
endometrial tissue) which was included in all reactions.
Immunohistochemistry of Fallopian Tube for
nAChR7
Immunohistochemistry was performed using standard
techniques as previously described.10 AChR7 rab-
bit anti-human polyclonal antibody (Santa Cruz Bio-
technology, Santa Cruz, CA) was diluted 50-fold in
normal goat serum. Rabbit IgG, diluted to the same
concentration as the nAChR7 antibody, was used
as a negative control.
SDS-PAGE and Western Blotting for PROKR
and nAChR7 in Fallopian Tube and the
OE-E6/E7 Cell Line
Twenty micrograms of whole cell lysate was resolved by
SDS-PAGE, after which proteins were transferred to ni-
trocellulose. A lysate from Ishikawa cells stably express-
ing PROKR1 was used as a positive control for PROKR1
(data not shown). Membranes were blocked overnight at
4°C in 5% milk in Tris-buffered saline-tween (TBST).
Membranes were blotted with antibodies diluted in 1%
milk in TBST; rabbit anti-human PROKR1, 2500-fold (MBL
International Corporation, Woburn, MA) or rabbit anti-
human AChR7 polyclonal, 200-fold (Santa Cruz Bio-
technology, Santa Cruz, CA). These incubations were
performed for one hour at room temperature following
which the membranes were washed three times in TBST.
The membranes were then incubated with mouse anti-
rabbit-IgG conjugated to HRP diluted 20,000-fold in 1%
milk in TBST for one hour at room temperature. Mem-
branes were washed as above, and proteins were de-
tected using chemiluminescent HRP substrate (Millipore,
Watford, UK) and exposed to film (GE Health care, Little
Chalfont, UK). Membranes were stripped of PROKR1
antibody and reprobed, as above, with rabbit anti-
human -actin antibody (Abcam, Cambridge, UK), di-
luted 15,000-fold in 1% milk in TBST as a loading
control. Densitometry analysis was performed using
ImageJ software (NIH, Bethesda, MD), and the density
of PROKR1 was normalized to the density of -actin in
each well.
Treatment of Human Fallopian Tube Explants
with Cotinine
Fallopian tube explant culture was performed using four
Fallopian tubes from four individual patients as previously
described.10 Explants were treated with 40 ng/ml cotinine
(Sigma-Aldrich, Dorset, UK), which represents cotinine
concentrations found in the serum of passive smokers,21
and 400 ng/ml, the average concentration found in the
serum of active smokers in our study (Table 1). Explants
were also treated with equivalent amounts of ethanol as a
control for the cotinine diluent. Preliminary time-course
studies were performed to determine the optimal treat-
ment time for measuring changes in PROKR1 mRNA
expression. Based on those results, treatments were
performed on duplicate explants for 8 hours, at which
time the culture medium was removed and tissues
placed in 300 l of Trizol reagent (Invitrogen, Paisley,
UK) and frozen at 80°C until RNA extraction. RNA was
extracted using Trizol (Invitrogen) according to the
manufacturer’s instructions. After RNA extraction,
DNAase treatment was performed followed by sample
clean-up using the RNAeasy kit (Qiagen, West Sussex,
Table 2. qRT-PCR Primer and Probe Sequences
Primer/probe
(label) Sequence
PROK1 forward 5-GTGCCACCCCGGCAG-3
PROK1 reverse 5-AGCAAGGACAGGTGTGGTGC-3
PROK1 probe
(FAM)
5-ACAAGGTCCCCTTCTTCAGGAAACGCA-3
PROKR1 forward 5-TCTTACAATGGCGGTAAGTCCA-3
PROKR1 reverse 5-CTCTTCGGTGGCAGGCAT-3
PROKR1 probe
(FAM)
5-TGCAGACCTGGACCTCAAGACAATTGG-3
PROK2 forward 5-TTGGGCGGAGGATGCA-3
PROK2 reverse 5-AAATGAAGTCCGTAAACAGGCC-3
PROK2 probe
(FAM)
5-CACTTGCCCATGTCTGCCAGGCT-3
PROKR2 forward 5-GCTCTGTGCCTCCGTCAACT-3
PROKR2 reverse 5-CCAGCAAGGCATTGGTGG-3
PROKR2 probe
(FAM)
5-CCTGCGCACCGTCTCCCTCTACG-3
18S forward 5-CGGCTACCACATCCAAGGAA-3
18S reverse 5-GCTGGAATTACCGCGGCT-3
18S probe (VIC) 5-TGCTGGCACCAGACTTGCCCTC-3
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UK). RNA concentrations were then quantified using a
Nanodrop Spectrophotometer (Thermo Scientific, Wil-
mington, DE).
Treatment of OE-E6/E7 Cell Line with Cotinine
and the nAChR7 Receptor Antagonist
OE-E6/E7 cells22 were maintained in DMEM/F12 medium
supplemented with 10% fetal bovine serum (growth me-
dium) in 5% CO2 at 37°C. Cells were seeded at 500,000
cells per well in 12-well dishes and incubated for 24
hours. The growth medium was then removed and cells
washed once with PBS, after which serum-free DMEM/
F12 (maintenance medium) was added and the cells
maintained overnight. The medium was then removed
and cells were either pretreated with 2 g/ml -bungaro-
toxin, a nAChR7 antagonist (Biotium, Hayward CA,
USA) in maintenance medium for 30 minutes19 after
which 400 ng/ml cotinine (Sigma-Aldrich, Dorset, UK) in
maintenance medium was added or cells were treated
with 400 ng/ml cotinine alone. In all cases cells were also
treated with an equivalent amount of ethanol to control for
the cotinine diluent. Cells were treated for 8 hours, and
medium was then removed and cells harvested into 300
l of RLT buffer (Qiagen, West Sussex, UK) containing 10
l/ml -mercaptoethanol and stored at 80°C until RNA
extraction. RNA was extracted using the RNA easy kit
(Qiagen, West Sussex, UK), according to the manufac-
turer’s instructions which included a DNase treatment
step. After extraction, RNA concentrations were quanti-
fied as above. For protein analysis, treatments were per-
formed for 9 hours, the optimal time for detecting
changes in PROKR1 protein expression, determined by
preliminary time-course experiments. Cells were har-
vested in 250 l RIPA buffer (1% Triton X, 0.1% SDS, 150
mmol/L NaCl, 20 mmol/L Tris, pH 7.4). Lysates were
prepared by incubation of cells on ice for 15 minutes
followed by centrifugation at 13,000 rpm for 15 minutes
at 4°C to remove membranous material. Total protein
concentrations of the lysates were determined by
Bradford assay and measured using a Cobas Fara
(Roche Diagnostics, Welwyn Garden City, UK) centrif-
ugal analyzer.
Statistical Analysis
Statistical analyses were performed using GraphPad
Prism (version 5.0, GraphPad Software, La Jolla, CA).
Differences in PROKR levels in Fallopian tube from smok-
ers versus nonsmokers were determined using the Man-
n–Whitney test. Where q-RT-PCR found undetermined
transcript levels, samples were removed from the analy-
sis. Comparisons of PROKR1 levels in treated tissues and
OE-E6/E7 cells were performed using one-way analysis
of variance (analysis of variance) followed by Newman-
Keul’s post hoc analysis.
Results
Relationship between Patient Serum Cotinine
Concentrations and Self-Reported Smoking
Status
A very strong relationship was observed between serum
cotinine concentrations and the self-reported smoking
status of the patients in this study (Table 3). All smokers
had serum cotinine concentrations in excess of 160 ng/ml
while the concentration in the serum of nonsmokers did
not exceed 12 ng/ml, indicating that cotinine is a good
biomarker for smoking. A previous report has found that
nonsmokers have serum cotinine levels less than 40 ng/
ml.23 The concentrations reported in our patients are in
agreement with that study, and therefore samples were
divided into two groups: i) nonsmokers (cotinine 40
ng/ml) and ii) smokers (cotinine 40 ng/ml).
Relationship between PROK and PROKR
mRNA Expression in Fallopian Tube Tissue
and Serum Cotinine Levels
No significant differences in the levels of mRNA encoding
PROK1, PROK2, and PROKR2 in Fallopian tube were
found between smokers and nonsmokers. However, the
expression of mRNA encoding PROKR1 was found to be
significantly higher (approximately twofold; P  0.01) in
Fallopian tube from smokers compared to Fallopian tube
from nonsmokers (Figure 1A). These data suggest an
association between PROKR1 expression, serum cotin-
ine expression, and cigarette smoking. To investigate this
further, we treated Fallopian tube explants with 400 ng/ml
cotinine, a concentration lower than that found in the
Table 3. Cotinine Levels in Patient Sera and Self-Reported
Smoking Status of Patients
Sample #
Serum
cotinine
(ng/ml)
Self-reported
smoking status
Number
of years
smoking
1 5 Nonsmoker
2 11.3 Nonsmoker
3 5 Nonsmoker
4 8.6 Nonsmoker
5 7.4 Nonsmoker
6 5 Nonsmoker
7 5 Nonsmoker
8 5 Nonsmoker
9 5 Nonsmoker
10 5 Nonsmoker
11 161 Smoker 5–8
12 5 Nonsmoker
13 5 Nonsmoker
14 355 Smoker Unknown
15 5 Nonsmoker
16 500 Smoker 20–30
17 500 Smoker 20
18 5 Nonsmoker
19 500 Smoker 20
20 5 Nonsmoker
21 500 Smoker 10–15
22 500 Smoker 10
2512 Shaw et al
AJP November 2010, Vol. 177, No. 5
serum of all but one of the active smokers included in our
study, and found that this induced a significant two- to
threefold increase in PROKR1 mRNA expression (Figure
1B; P  0.05). Past Chlamydia trachomatis infection was
considered a potential confounder (another major risk
factor for ectopic pregnancy). This was addressed by
measuring serum levels of PgP antibodies (indicative of
past Chlamydia infection) in patient serum by ELISA.
There was no relationship between serum PgP and
PROKR1 mRNA expression levels (data not shown).
Expression of Nicotinic Acetylcholine Receptor
-7 (nAChR7) by Fallopian Tube and
OE-E6/E7 Cells
The epithelium of the ampullary region of the human
Fallopian tube was found to express AChR7 by immu-
nohistochemistry using a specific rabbit polyclonal anti-
body (Figure 2A, main image) that was not observed
using a control rabbit IgG (Figure 2A, inset). The same
specific antibody was used to probe lysates of OE-E6/E7
cells by Western blotting and show that this cell line also
expresses nAChR7, as indicated by a band at the
predicted molecular weight of 55 kDa (Figure 2B). Thus,
both Fallopian tube explants and the OE-E6/E7 cell line
have the potential to respond to cotinine via ligation of the
nAChR7.
Effect of the nAChR7 Receptor Antagonist
-Bungarotoxin on Cotinine-Induced on
PROKR1 Expression in OE-E6/E7 Cells
Consistent with the previous observations in Fallopian
tube, OE-E6/E7 cells were found to up-regulate PROKR1
mRNA levels in response to 400 ng/ml cotinine (Figure
3A; P  0.05). This effect was found to be negated by
pretreatment of cells with -bungarotoxin (Figure 3A).
Western blot and densitometry analysis (n  6) show
that PROKR1 protein levels were also increased in
OE-E6/E7 cells exposed to 400 ng/ml cotinine, an ef-
fect that was also negated by pretreatment with -bun-
garotoxin (Figure 3B).
Figure 1. PROKR mRNA levels in Fallopian tubes from smokers and non-
smokers and in Fallopian tube explants treated with cotinine. A: The women
were divided into two groups, nonsmokers and smokers, based on their
serum cotinine levels and self-reported smoking status. PROK1, PROK2,
PROKR1, and PROKR2 mRNA levels were measured by q-RT-PCR. B: Fallo-
pian tube explants were cultured and treated for 8 hours with cotinine at
levels reported to be representative of passive (40 ng/ml) and active (400
ng/ml) smokers, and PROKR1 mRNA levels were measured using q-RT-PCR.
*P  0.05, **P  0.01.
Figure 2. Expression of nAChR7 in Fallopian tubes and OE-E6/E7 cells.
A: Immunohistochemical staining of Fallopian tubes with rabbit polyclonal
IgG antibody specific for nAChR7 (main image) and control rabbit IgG
(inset) at 100 magnification. B: Lysates of OE-E6/E7 cells resolved by
SDS-PAGE, transferred to nitrocellulose, and blotted with a rabbit IgG anti-
body specific for nAChR7.
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Discussion
This study provides evidence that altered Fallopian tube
PROKR1 expression may explain the link between smok-
ing and tubal ectopic pregnancy. Smoking is associated
with other adverse effects on human reproduction, in
addition to tubal ectopic pregnancy, such as infertility
and spontaneous abortion,24 making this is an important
finding in the broader context of reproductive health.
We recently reported that there are significantly lower
levels of PROKR1 in nonpregnant Fallopian tube col-
lected during the follicular phase compared to the mid-
luteal phase (so called ‘window of implantation’) of the
menstrual cycle.10,25 We also showed that Fallopian tube
obtained from women with tubal ectopic pregnancy,
where tubal implantation had occurred, had significantly
lower levels of PROKR compared to nonpregnant Fallo-
pian tube.10 The difficulty in studying implantation is that
tissues are collected after an implantation event has oc-
curred, making it hard to ascertain whether differences
observed are the result of a predisposing factor or im-
plantation itself. However, our previous findings,10 to-
gether with the purported roles of PROK1 in intrauterine
implantation,13–15 led us to hypothesize that dysregu-
lated PROKR1 expression might predispose the tubal
environment to ectopic pregnancy.
Herein, we demonstrate that PROKR1 expression is
increased in Fallopian tube from women who are smok-
ers. We also show that PROK1 levels appear to be de-
creased in Fallopian tube from smokers compared to
nonsmokers, however this difference was not statistically
significant. It could be that a negative feedback mech-
anism exists between PROKR1 and PROK1. We report
that a metabolite of cigarette smoke, cotinine, in-
creases PROKR1 expression in cultured Fallopian tube
explants and in the immortalized oviductal epithelial cell
line, OE-E6/E7. Nicotine is known to signal through nico-
tinic acetylcholine receptors (nAChR)18 with cotinine re-
ported to signal through a specific member of this family,
nAChR7.19 We demonstrate that human Fallopian
tube epithelium and the OE-E6/E7 cell line express
nAChR7. We also establish that treatment of OE-E6/E7
cells with a specific and potent nAChR7 antagonist
(-bungarotoxin), before cotinine treatment, negates the
increase in PROKR expression observed when cells are
treated with cotinine alone.
It is possible that increased PROKR1 expression in the
Fallopian tube, as a result of smoking, predisposes the
tubal environment to implantation through dysregulation
of factors important for embryo receptivity and angiogen-
esis. PROK1 has been demonstrated to regulate the ex-
pression of genes important for implantation, such as
cyclooxygenase 2 (COX2), dickkhopf-1 (DKK1), and LIF,
in the human endometrium.13 Furthermore, PROK1 was
recently reported to enhance the adhesion of human
trophoblast cells to extracellular matrix proteins.15 This
effect was shown to be mediated through PROK1 up-
regulation of LIF, suggesting that increased PROK1 ac-
tivity may result in enhanced endometrial receptivity.
PROKs are potent angiogenic factors.26 Angiogenesis is
an important feature of successful intrauterine implanta-
tion allowing the uterine vasculature to adapt to meet the
nutritional needs of the growing fetus,27 further suggest-
ing that increased PROK signaling may lead to a tubal
microenvironment predisposed to implantation.
Interestingly, cigarette smoking is associated with a
decreased risk of preeclampsia, and it is hypothesized
that dysregulated PROK1 expression, and the develop-
ment of a proangiogenic phenotype during early placen-
tation, may be implicated in the development of this
condition.28 Similar to our findings in the Fallopian tube, it
is possible that the effects of cigarette smoke on the
placenta are mediated through nAChR7 resulting in
up-regulated PROKR1 expression and increased PROK1
activity. Thus, we conclude that the human Fallopian tube
serves as a useful model to evaluate the effect of ciga-
rette smoke, and its components, on a reproductive or-
gan remote to the site of inhalation, and in a more general
sense on a variety of biological functions.
Figure 3. Effect of the nAChR7, -bungarotoxin, on cotinine-induced
PROKR1 expression in OE-E6/E7 cells. OE-E6/E7 cells were treated with 400
ng/ml cotinine or pretreated for 30 minutes with the nAChR7 antagonist,
-bungarotoxin, followed by 400 ng/ml cotinine. Cells were treated with
cotinine for 8 hours for mRNA analysis (A) and for 9 hours for protein
analysis (B). *P  0.05.
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